Lavinia Flaskamp

Ms. Lavinia Flaskamp

Ludwig-Maximilians-Universität München, Munich, Bavaria, Germany
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2022 in Cells
Verified
Journal Article
Open access
PDF file
LFLavinia Flaskamp
Lavinia Flaskamp
CRConstanze Roubal
Constanze Roubal
SUSteven Uddin
Steven Uddin
FSFranziska Sotzny
Franziska Sotzny
CKClaudia Kedor
Claudia Kedor
MSMartina Seifert
Martina Seifert
A proportion of COVID-19 reconvalescent patients develop post-COVID-19 syndrome (PCS) including a subgroup fulfilling diagnostic criteria of Myalgic encephalomyelitis/Chronic Fatigue Syndrome (PCS/CFS). Recently, endothelial dysfunction (ED) has been demonstrated in these patients, but the mechanisms remain elusive. Therefore, we investigated the effects of patients’ sera on endothelia cells (ECs) in vitro. PCS (n = 17), PCS/CFS (n = 13), and healthy controls (HC, n = 14) were screened for serum anti-endothelial cell autoantibodies (AECAs) and dysregulated cytokines. Serum-treated ECs were analysed for the induction of activation markers and the release of small molecules by flow cytometry. Moreover, the angiogenic potential of sera was measured in a tube formation assay. While only marginal differences between patient groups were observed for serum cytokines, AECA binding to ECs was significantly increased in PCS/CFS patients. Surprisingly, PCS and PCS/CFS sera reduced surface levels of several EC activation markers. PCS sera enhanced the release of molecules associated with vascular remodelling and significantly promoted angiogenesis in vitro compared to the PCS/CFS and HC groups. Additionally, sera from both patient cohorts induced the release of molecules involved in inhibition of nitric oxide-mediated endothelial relaxation. Overall, PCS and PCS/CFS patients′ sera differed in their AECA content and their functional effects on ECs, i.e., secretion profiles and angiogenic potential. We hypothesise a pro-angiogenic effect of PCS sera as a compensatory mechanism to ED which is absent in PCS/CFS patients.

11 April 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
LRLisa Rausch
Lisa Rausch
LFLavinia Flaskamp
Lavinia Flaskamp
AAAshretha Ashokkumar
Ashretha Ashokkumar
ATAnne Trefzer
Anne Trefzer
CRChristine Ried
Christine Ried
JKJan Kranich
Jan Kranich
CD8 + T cells are crucial for the clearance of viral infections. During the acute phase, proinflammatory conditions increase the amount of circulating phosphatidylserine + (PS) extracellular vesicles (EVs). These EVs interact especially with CD8 + T cells; however, it remains unclear whether they can actively modulate CD8 + T cell responses. In this study, we have developed a method to analyze cell-bound PS + EVs and their target cells in vivo. We show that EV + cell abundance increases during viral infection and that EVs preferentially bind to activated, but not naive, CD8 + T cells. Superresolution imaging revealed that PS + EVs attach to clusters of CD8 molecules on the T cell surface. Furthermore, EV-binding induces antigen (Ag)-specific TCR signaling and increased nuclear translocation of the transcription factor Nuclear factor of activated T-cells (NFATc1) in vivo. EV-decorated but not EV-free CD8 + T cells are enriched for gene signatures associated with T-cell receptor signaling, early effector differentiation, and proliferation. Our data thus demonstrate that PS + EVs provide Ag-specific adjuvant effects to activated CD8 + T cells in vivo.

14 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
LFLavinia Flaskamp
Lavinia Flaskamp
MPMonica Prechtl
Monica Prechtl
ASAnnkathrin Scheck
Annkathrin Scheck
WHWenbo Hu
Wenbo Hu
CRChristine Ried
Christine Ried
TBThomas Brocker
Thomas Brocker
Phosphatidylserine (PS) is a well-established marker for apoptotic cells and activated platelets, and it is also found on extracellular vesicles (EVs). However, the frequency of PS + EVs remains a topic of debate, probably due to the distinct lipid composition of EVs, which varies with the source material. This variation underscores the need for highly sensitive detection reagents to accurately differentiate between PS + and PS − EVs. To address this issue, we compared several PS-binding reagents for the staining of blood EVs, including milk fat globule factor E8 (MFG-E8, lactadherin), a derivative of MFG-E8, and Annexin V, the most used compound in the literature. Here, we demonstrate the predominance of PS + EVs in both murine and human blood and reveal significant differences in the affinities of the PS-binding proteins. With approximately 90% of the detected blood EVs being PS + , we utilized a derivative of MFG-E8 for in vivo monitoring of both circulating and cell-bound EVs, providing a novel tool to analyze endogenous EV kinetics. Our findings showed that murine PS + plasma EVs were rapidly cleared from circulation (∼50% after 30 minutes), yet they remained present on splenic B cells and monocytes/macrophages. In conclusion, MFG-E8-based reagents enable externalized PS to serve as a universal EV marker, greatly improving EV isolation, standardizing EV quantification, and facilitating diagnostic EV monitoring and disease biomarker discovery.